Early research (Phase 1)Study completedNCT03669250What this trial is testingCVN058 Effect on Mismatch Negativity in SchizophrenicsWho this might be right forSchizophrenia Cerevance Alpha, Inc. 22
Not applicableStudy completedNCT00174200What this trial is testingStudy To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With RisperidoneWho this might be right forSchizophreniaPsychotic Disorders Pfizer 20
Not applicableWithdrawnNCT01246128What this trial is testingNicotinic Receptor Density in Smoking and Nonsmoking SchizophrenicsWho this might be right forSchizophrenia National Institute on Drug Abuse (NIDA)
Not applicableStudy completedNCT00753051What this trial is testingTreat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)Who this might be right forSchizophrenia Khon Kaen University 18
Testing effectiveness (Phase 2)Study completedNCT00218218What this trial is testingEffects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With SchizophreniaWho this might be right forSchizophrenia and Disorders With Psychotic FeaturesTobacco Use DisorderSchizophrenia National Institute on Drug Abuse (NIDA) 48
Testing effectiveness (Phase 2)Study completedNCT04754750What this trial is testingDifferences in Schizophrenia With One-month and 3-month Paliperidone Palmitate TreatmentWho this might be right forSchizophrenics Calo Psychiatric Center 72
Not applicableUnknownNCT00645580What this trial is testingGenetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive FunctionWho this might be right forSchizophrenia Sha'ar Menashe Mental Health Center 15
Post-approval studies (Phase 4)Study completedNCT02360319What this trial is testingComparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase SchizophrenicsWho this might be right forSchizophrenia Vanguard Research Group 489
Testing effectiveness (Phase 2)Study completedNCT00136760What this trial is testingContingent Incentives Plus Bupropion for Smoking in People With SchizophreniaWho this might be right forSchizophrenia and Disorders With Psychotic FeaturesTobacco Use Disorder Brown University 57
Not applicableEnded earlyNCT03917355What this trial is testingNonverbal Synchrony, Therapeutic Alliance and Treatment Engagement in First Episode SchizophreniaWho this might be right forSchizophrenics University Hospital, Montpellier 7
Early research (Phase 1)Study completedNCT00986531What this trial is testingThe Effects AZD8529 on Cognition and Negative Symptoms in SchizophrenicsWho this might be right forSchizophrenia AstraZeneca 59
Testing effectiveness (Phase 2)Study completedNCT00000274What this trial is testingFlupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9Who this might be right forCocaine-Related DisordersSubstance-Related Disorders National Institute on Drug Abuse (NIDA) 60
Not applicableStudy completedNCT03663465What this trial is testingThe Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With AntipsychoticsWho this might be right forSchizophrenia Calo Psychiatric Center 135
Testing effectiveness (Phase 2)Study completedNCT00218231What this trial is testingEffect of Bupropion on Smoking Behavior in Smokers With SchizophreniaWho this might be right forSchizophreniaTobacco Use Disorder National Institute on Drug Abuse (NIDA) 48